Xtant Medical Holdings, Inc.(XTNT)
Health Care Equipment
Orthopedic Implants & Devices
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-04-14 | ORBIMED ADVISORS LLC 10% Owner | Sale | -73,114,592 | -100.00%0 | $0.42 | $30,708,129 | View SEC filing | |
| 2023-11-17 | Brandt Kevin D Chief Commercial Officer | Purchase | +41,670 | +5.38%815,860 | $1.20 | $49,837 | View SEC filing | |
| 2023-01-19 | Neils Scott C Chief Financial Officer | Sale | -8,673 | -2.10%403,960 | $0.61 | $5,283 | View SEC filing | |
| 2022-10-20 | Browne Sean E President and CEO | Sale | -131,100 | -8.01%1,506,584 | $0.65 | $85,828 | View SEC filing | |
| 2022-10-11 | Vizirgianakis Stavros G. Director | Purchase | +2,831,075 | +78.95%6,416,930 | $0.38 | $1,087,133 | View SEC filing | |
| 2022-08-17 | Brandt Kevin D Chief Commercial Officer | Sale | -23,000 | -3.17%703,571 | $0.49 | $11,222 | View SEC filing | |
| 2022-08-17 | Neils Scott C Chief Financial Officer | Sale | -6,370 | -1.52%412,633 | $0.48 | $3,065 | View SEC filing | |
| 2018-02-26 | Rizzo Matthew Director, 10% Owner | Purchase | +945,819 | -37.28%3,316,128 | $7.20 | $6,809,897 | View SEC filing | |
| 2018-02-26 | Eggenberg Michael Director, 10% Owner | Purchase | +945,819 | -37.28%3,316,128 | $7.20 | $6,809,897 | View SEC filing | |
| 2018-02-23 | ORBIMED ADVISORS LLC Director, 10% Owner | Purchase | +945,819 | -37.28%3,316,128 | $7.20 | $6,809,897 | View SEC filing | |
| 2016-05-10 | Goldberger Daniel S Chief Executive Officer | Purchase | +5,000 | +6.13%86,522 | $2.34 | $11,700 | View SEC filing | |
| 2015-12-03 | Swanson Kent L Director | Purchase | +3,300 | +4.13%83,128 | $2.83 | $9,343 | View SEC filing | |
| 2015-11-23 | Kirschman David Louis EVP & Chief Scientific Officer | Purchase | +2,000 | +0.12%1,701,063 | $2.99 | $5,983 | View SEC filing | |
| 2015-11-20 | Swanson Kent L Director | Purchase | +5,000 | +6.68%79,828 | $3.00 | $14,998 | View SEC filing | |
| 2015-11-19 | Kirschman David Louis EVP & Chief Scientific Officer | Purchase | +2,000 | +0.12%1,699,063 | $2.90 | $5,805 | View SEC filing | |
| 2015-11-16 | Goldberger Daniel S Chief Executive Officer | Purchase | +3,000 | +23.98%15,510 | $2.80 | $8,400 | View SEC filing | |
| 2015-09-09 | DEEDRICK JOHN ARTHUR Director | Purchase | +6,793 | +69.12%16,621 | $3.68 | $24,998 | View SEC filing | |
| 2015-09-09 | LOPACH MICHAEL A Director | Purchase | +10,869 | +320.71%14,258 | $3.68 | $39,998 | View SEC filing | |
| 2015-09-09 | Swanson Kent L Director | Purchase | +30,000 | +66.92%74,828 | $3.68 | $110,400 | View SEC filing | |
| 2015-09-09 | WICKWIRE JON M. Director | Purchase | +10,869 | +53.34%31,247 | $3.68 | $39,998 | View SEC filing | |
| 2015-09-09 | Goldberger Daniel S Chief Executive Officer | Purchase | +81,522 | +100.00%81,522 | $3.68 | $300,001 | View SEC filing | |
| 2014-07-21 | HOLMES DARREL LEE COO | Sale | -50,000 | -81.10%11,656 | $0.74 | $37,000 | View SEC filing | |
| 2014-05-22 | Goldberger Daniel S President and CEO | Purchase | +25,000 | +24.98%125,100 | $0.65 | $16,250 | View SEC filing | |
| 2014-05-20 | JUDA GREGORY ALEXANDER Chief Scientific Officer | Purchase | +20,000 | +100.00%40,000 | $0.69 | $13,796 | View SEC filing | |
| 2014-05-09 | COOK GUY S 10% Owner | Sale | -1,365,000 | -26.43%3,800,000 | $0.66 | $900,900 | View SEC filing |
1-25 of 89